1. 353 Amlitelimab reduces serum IL-13 in a phase 2a clinical trial in atopic dermatitis without impacting T-cell expansion in a T-cell recall assay. (25th January 2023) Authors: Weidinger, Stephan; Cork, Michael; Reich, Adam ; Bieber, Thomas; Lucchesi, Davide ; Rynkiewicz, Natalie ; Sainson, Richard C A ; Chen, Ron ; Prandi, Francesca; van Krinks, Cassandra ; Stebegg, Marisa; Porter-Brown, Ben Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗